Search

Author/Creator Bermel, Robert A

1. Clinical features and outcomes of COVID-19 despite SARS-CoV-2 vaccination in people with multiple sclerosis. Issue 4 (October 2021)

Authors:
Rose, Deja R; Mahadeen, Ahmad Z; Carlson, Alise K; Planchon, Sarah M; Sedlak, Jennifer; Husak, Scott; Bermel, Robert A; Cohen, Jeffrey A; Moss, Brandon P
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 7:Issue 4(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparative efficacy and discontinuation of dimethyl fumarate and fingolimod in clinical practice at 24-month follow-up. Issue 3 (August 2017)

Authors:
Hersh, Carrie M; Love, Thomas E; Bandyopadhyay, Anasua; Cohn, Samuel; Hara-Cleaver, Claire; Bermel, Robert A; Fox, Robert J; Cohen, Jeffrey A; Ontaneda, Daniel
Journal:
Multiple sclerosis journal, experimental, translational and clinical
Issue:
Volume 3:Issue 3(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health Solutions. (June 2022)

Authors:
Cohen, Jeffrey A; Bermel, Robert A; Grossman, Cynthia I; Hersh, Carrie M; Hyland, Megan; Mowry, Ellen M; Naismith, Robert; Naylor, Maria L; Nicholas, Jacqueline; Rajbhandar, Rajani; Singh, Carol M; Tintorè, Mar; Zabalza, Ana; Ziemssen, Tjalf; Williams, James R; Montalban, Xavier
Journal:
Multiple sclerosis
Issue:
Volume 28:Number 7(2022)
Page Start:
1131
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Multiple sclerosis management during the COVID-19 pandemic. (September 2020)

Authors:
Moss, Brandon P; Mahajan, Kedar R; Bermel, Robert A; Hellisz, Kelsey; Hua, Le H; Hudec, Timothy; Husak, Scott; McGinley, Marisa P; Ontaneda, Daniel; Wang, Zhini; Weber, Malory; Tagliani, Paula; Cárdenas-Robledo, Simón; Zabalza, Ana; Arrambide, Georgina; Carbonell-Mirabent, Pere; Rodríguez-Barranc...
Journal:
Multiple sclerosis
Issue:
Volume 26:Number 10(2020)
Page Start:
1163
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Neurofilament light chain in a phase 2 clinical trial of ibudilast in progressive multiple sclerosis. (November 2021)

Authors:
Fox, Robert J; Raska, Paola; Barro, Christian; Karafa, Matthew; Konig, Victoria; Bermel, Robert A; Chase, Marianne; Coffey, Christopher S; Goodman, Andrew D; Klawiter, Eric C; Naismith, Robert T; Kuhle, Jens
Journal:
Multiple sclerosis
Issue:
Volume 27:Number 13(2021)
Page Start:
2014
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Optical coherence tomography outcomes from SPRINT-MS, a multicenter, randomized, double-blind trial of ibudilast in progressive multiple sclerosis. (August 2021)

Authors:
Bermel, Robert A; Fedler, Janel K; Kaiser, Peter; Novalis, Cindy; Schneebaum, Jeff; Klingner, Elizabeth A; Williams, Dawn; Yankey, Jon W; Ecklund, Dixie J; Chase, Marianne; Naismith, Robert T; Klawiter, Eric C; Goodman, Andrew D; Coffey, Christopher S; Fox, Robert J
Journal:
Multiple sclerosis
Issue:
Volume 27:Number 9(2021)
Page Start:
1384
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosis. (April 2018)

Authors:
Cohen, Jeffrey A; Imrey, Peter B; Planchon, Sarah M; Bermel, Robert A; Fisher, Elizabeth; Fox, Robert J; Bar-Or, Amit; Sharp, Susan L; Skaramagas, Thomai T; Jagodnik, Patricia; Karafa, Matt; Morrison, Shannon; Reese Koc, Jane; Gerson, Stanton L; Lazarus, Hillard M
Journal:
Multiple sclerosis
Issue:
Volume 24:Number 4(2018)
Page Start:
501
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗